1. Home
  2. ELTX vs TII Comparison

ELTX vs TII Comparison

Compare ELTX & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$2.89

Market Cap

185.4M

Sector

Health Care

ML Signal

N/A

Logo Titan Mining Corporation

TII

Titan Mining Corporation

HOLD

Current Price

$1.96

Market Cap

198.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
TII
Founded
2011
2012
Country
United States
Canada
Employees
N/A
167
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
198.5M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ELTX
TII
Price
$2.89
$1.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$18.00
$6.38
AVG Volume (30 Days)
992.3K
447.8K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
N/A
Revenue This Year
N/A
$4.20
Revenue Next Year
N/A
$3.46
P/E Ratio
N/A
$25.66
Revenue Growth
N/A
N/A
52 Week Low
$2.66
$1.81
52 Week High
$16.00
$5.65

Technical Indicators

Market Signals
Indicator
ELTX
TII
Relative Strength Index (RSI) 34.51 37.79
Support Level $2.72 $1.89
Resistance Level $5.38 $2.47
Average True Range (ATR) 0.24 0.13
MACD 0.22 -0.02
Stochastic Oscillator 3.95 7.60

Price Performance

Historical Comparison
ELTX
TII

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About TII Titan Mining Corporation

Titan Mining Corp is a Canadian natural resources company. The company is engaged in the acquisition, exploration, development, and extraction of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States, and Kilbourne Graphite Project. The Company operates one reportable segment, mineral production and exploration in the United States.

Share on Social Networks: